Abstract
Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: a pilot study.
P Sambo, D Amico, R Giacomelli, M Matucci-Cerinic, F Salsano, G Valentini and A Gabrielli
The Journal of Rheumatology October 2001, 28 (10) 2257-2262;
P Sambo
D Amico
R Giacomelli
M Matucci-Cerinic
F Salsano
G Valentini
In this issue
Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: a pilot study.
P Sambo, D Amico, R Giacomelli, M Matucci-Cerinic, F Salsano, G Valentini, A Gabrielli
The Journal of Rheumatology Oct 2001, 28 (10) 2257-2262;